BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhuo JY, Lu D, Lin ZY, Cen BN, Wei XY, Xie HY, Zheng SS, Xu X. CC motif chemokine ligand 16 inhibits the progression of liver cirrhosis via inactivating hepatic stellate cells. Hepatobiliary Pancreat Dis Int 2020;19:440-8. [PMID: 31948840 DOI: 10.1016/j.hbpd.2019.12.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Tavener SK, Jewell DE, Panickar KS. The Increase in Circulating Levels of Pro-Inflammatory Chemokines, Cytokines, and Complement C5 in Canines with Impaired Kidney Function. CIMB 2022;44:1664-76. [DOI: 10.3390/cimb44040114] [Reference Citation Analysis]
2 Zhong S, Zhang T, Tang L, Li Y. Cytokines and Chemokines in HBV Infection. Front Mol Biosci 2021;8:805625. [PMID: 34926586 DOI: 10.3389/fmolb.2021.805625] [Reference Citation Analysis]
3 She S, Ren L, Chen P, Wang M, Chen D, Wang Y, Chen H. Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease. Front Immunol 2022;13:812431. [DOI: 10.3389/fimmu.2022.812431] [Reference Citation Analysis]
4 Chen RY, Yen CJ, Lin YJ, Wang JM, Tasi TF, Huang YC, Liu YW, Tsai HW, Lee MH, Hung LY. CPAP enhances and maintains chronic inflammation in hepatocytes to promote hepatocarcinogenesis. Cell Death Dis 2021;12:983. [PMID: 34686650 DOI: 10.1038/s41419-021-04295-2] [Reference Citation Analysis]
5 Zhuo J, Lu D, Lin Z, Yang X, Yang M, Wang J, Tao Y, Wen X, Li H, Lian Z, Cen B, Dong S, Wei X, Xie H, Zheng S, Shen Y, Xu X. The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib. Cell Death Dis 2021;12:1084. [PMID: 34785656 DOI: 10.1038/s41419-021-04320-4] [Reference Citation Analysis]